MedPath

The Case Comprehensive Cancer Center

The Case Comprehensive Cancer Center logo
🇺🇸United States
Ownership
Subsidiary
Established
1826-01-01
Employees
5K
Market Cap
-
Website
http://www.case.edu/cancer

Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors

Phase 1
Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-05-03
Last Posted Date
2014-01-07
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
25
Registration Number
NCT00003768
Locations
🇺🇸

Ireland Cancer Center, Cleveland, Ohio, United States

Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer

Phase 2
Withdrawn
Conditions
Breast Cancer
First Posted Date
2004-04-29
Last Posted Date
2010-06-10
Lead Sponsor
Case Comprehensive Cancer Center
Registration Number
NCT00006261
Locations
🇺🇸

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Biological: filgrastim
Drug: CMF regimen
Procedure: autologous bone marrow transplantation
Procedure: surgical procedure
Radiation: radiation therapy
First Posted Date
2004-04-28
Last Posted Date
2013-01-28
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
39
Registration Number
NCT00003953
Locations
🇺🇸

Metro Health Medical Center, Cleveland, Ohio, United States

🇺🇸

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer

Phase 3
Completed
Conditions
Lung Cancer
First Posted Date
2004-04-14
Last Posted Date
2014-01-09
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
4
Registration Number
NCT00003917
Locations
🇺🇸

Spartanburg Regional Healthcare System, Spartanburg, South Carolina, United States

🇺🇸

Veterans Affairs Medical Center - West Los Angeles, Los Angeles, California, United States

🇺🇸

Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital), Hines, Illinois, United States

and more 50 locations

Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia

Not Applicable
Completed
Conditions
Leukemia
Interventions
Biological: alemtuzumab
First Posted Date
2004-04-13
Last Posted Date
2014-01-09
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
2
Registration Number
NCT00021151
Locations
🇺🇸

Ireland Cancer Center, Cleveland, Ohio, United States

Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Lymphoma
First Posted Date
2004-04-07
Last Posted Date
2010-06-11
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
5
Registration Number
NCT00003110
Locations
🇺🇸

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Stereotactic Radiation Therapy in Treating Patients With Brain Metastases

Phase 2
Completed
Conditions
Metastatic Cancer
First Posted Date
2004-03-08
Last Posted Date
2020-07-27
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
10
Registration Number
NCT00006259
Locations
🇺🇸

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors

Phase 1
Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-03-08
Last Posted Date
2010-06-11
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
5
Registration Number
NCT00006018
Locations
🇺🇸

Ireland Cancer Center at University Hospitals Case Medical Center, Cleveland, Ohio, United States

🇺🇸

Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States

Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome

Phase 1
Completed
Conditions
Leukemia
Myelodysplastic Syndromes
First Posted Date
2004-02-25
Last Posted Date
2010-06-11
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
31
Registration Number
NCT00005593
Locations
🇺🇸

Ireland Cancer Center at University Hospitals Case Medical Center, Cleveland, Ohio, United States

Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer

Phase 1
Terminated
Conditions
Head and Neck Cancer
First Posted Date
2004-02-11
Last Posted Date
2010-06-11
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
4
Registration Number
NCT00077103
Locations
🇺🇸

Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States

🇺🇸

Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

🇺🇸

Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath